Humacyte publications and clinical trials.

Bylsma

2019: “Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis patients with Medicare Coverage 2012-2014”

 

Nordyke

2019: “Cost Attributable to Arteriovenous Fistulae and Arteriovenous Graft Placements in Hemodialysis patients with Medicare Coverage”

 

Publications

Science Translational Medicine​

Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.

March 27, 2019

 

Bylsma

2017: “Arteriovenous fistulae for Hemodialysis: A Systematic Review and Meta-Anaylsis of Efficacy and Safety Outcomes”

 

The Lancet

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials

May 14, 2016

Science Translational Medicine​

Readily Available Tissue-Engineered Vascular Grafts

February 2, 2011

Humanity

Clinical Trial for AV Access

HAV-ACCESS

Human Acellular Vessel – A Controlled Comparison
of Efficacy and Safety Study

Human Acellular Vessel vs. Arteriovenous Fistula
for Hemodialysis Access

Phase II Clinical Trial for Peripheral Arterial Disease

Scroll to Top